We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 396 results
  1. Exploring new histone deacetylase 6 inhibitors and their effects on reversing the α-tubulin deacetylation and cell morphology changes caused by methamphetamine

    Indazole-based HDAC6 inhibitors with novel zinc-binding modifications were synthesized and evaluated to determine their potential to inhibit HDAC6....

    Sunil K. Gupta, Khan Hashim Ali, ... Young Ho Seo in Archives of Pharmacal Research
    Article 30 September 2023
  2. In Silico and In Vitro Antigiardiasic Potential of Grape Pomace Polyphenols Extracted by Hybrid Microwave-Ultrasound Methodology

    Grape pomace is an agro-industrial residue with polyphenolic compounds that have different biological activities. There are few reports of the...

    Mariana Garza-Ontiveros, José Roberto Vargas-Villanueva, ... Lissethe Palomo-Ligas in Revista Brasileira de Farmacognosia
    Article 11 November 2023
  3. Preparation and Mechanism of the Antitumor Action of a 4H-Aminochromene Compound

    We report here studies of the antitumor action of a 4 H -aminochromene compound in a xenograft model of ALK-expressing lung adenocarcinoma in humanized nude...

    E. A. Samyshina, E. V. Blinova, ... K. K. Arutyunyan in Pharmaceutical Chemistry Journal
    Article 30 March 2022
  4. ACY-241, an HDAC6 inhibitor, overcomes erlotinib resistance in human pancreatic cancer cells by inducing autophagy

    Histone deacetylase 6 (HDAC6) is a promising target for cancer treatment because it regulates cell mobility, protein trafficking, cell growth,...

    Seong-Jun Park, Sang Hoon Joo, ... Chul-Ho Jeong in Archives of Pharmacal Research
    Article 10 November 2021
  5. Insights into the structure and tubulin-targeted anticancer potential of N-(3-bromobenzyl) noscapine

    Background

    Noscapine is a non-narcotic, antitussive alkaloid isolated from plants of Papaveraceae family. This benzylisoquinoline alkaloid and its...

    Sanith Cheriyamundath, Tejashree Mahaddalkar, ... Manu Lopus in Pharmacological Reports
    Article 06 September 2018
  6. Changes in expression of mesothelial BBS genes in 2D and 3D after lithium chloride and ammonium sulphate induction of primary cilium disturbance: a pilot study

    Background

    Malignant pleural mesothelioma (MPM), a rare and aggressive pleural tumor, has significant histological and molecular heterogeneity....

    Erasmia Rouka, Rajesh M. Jagirdar, ... Sotirios G. Zarogiannis in Pharmacological Reports
    Article Open access 04 August 2023
  7. Antibody–drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry

    Engineering approaches using antibody drug conjugates (ADCs) and bispecific antibodies (bsAbs) are designed to overcome the limitations of...

    Yeji Hong, Su-Min Nam, Aree Moon in Archives of Pharmacal Research
    Article 06 March 2023
  8. Current Prospects and Clinical Status of Microalgae Derived Chemotherapeutics

    Globally, despite clinical advancements made over a decade, cancer remains a prominent cause of death. Numerous drugs have been chemically...

    Vandana Joshi, Navneeta Bharadvaja in Revista Brasileira de Farmacognosia
    Article 22 March 2023
  9. Deciphering the Antidiarrheal Mechanisms of Macleaya cordata by Combining Network Pharmacology, Molecular Docking, and Experimental Evaluations

    Diarrhea continues to be a major public health problem and is thought to be the cause of 525,000 child fatalities annually. Studies have shown that Mac...

    Liyang Guo, Xuexue Xue, ... Zunlai Sheng in Revista Brasileira de Farmacognosia
    Article 31 January 2024
  10. Mitragynine inhibits hippocampus neuroplasticity and its molecular mechanism

    Background

    Mitragynine (MIT), the primary indole alkaloid of kratom ( Mitragyna speciosa ), has been associated with addictive and cognitive decline...

    Suleiman Yunusa, Zurina Hassan, Christian P. Müller in Pharmacological Reports
    Article Open access 04 November 2023
  11. 6′-Sialylactose abolished lipopolysaccharide-induced inflammation and hyper-permeability in endothelial cells

    Disruption of the endothelial barrier function and reduction in cell migration leads to endothelial dysfunction. One of the most abundant human milk...

    Dung Van Nguyen, Thuy Le Lam Nguyen, ... Kyung-Sun Heo in Archives of Pharmacal Research
    Article 19 November 2022
  12. Anticancer Activity–Structure Relationship of Quinolinone-Core Compounds: An Overall Review

    Quinolinone/quinoline is one of the most unique structures in the discovery of heterocycles that have attracted much attention in the field of...

    Hüseyin Kerim Beker, Işıl Yıldırım in Pharmaceutical Chemistry Journal
    Article 12 January 2023
  13. Inhibition of autophagy with chloroquine dysregulates mitochondrial quality control and energetics in adipocytes

    Autophagy is a complex degradation pathway through which damaged or dysfunctional proteins and organelles are removed. Its pharmacological modulators...

    Hafiz Muhammad Ahmad Javaid, Hwayeon Lim, ... Joo Young Huh in Archives of Pharmacal Research
    Article 28 October 2022
  14. Recent progress in biologically active indole hybrids: a mini review

    The indole moiety is one of the most widespread heterocycles found in both natural products and biological systems. Indoles have important biological...

    Esraa Mahmoud, Alaa M. Hayallah, ... Mohamad Abdel-Aziz in Pharmacological Reports
    Article 20 May 2022
  15. Human milk oligosaccharides 3′-sialyllactose and 6′-sialyllactose attenuate LPS-induced lung injury by inhibiting STAT1 and NF-κB signaling pathways

    Acute lung injury (ALI) is the leading cause of respiratory diseases induced by uncontrolled inflammation and cell death. Lipopolysaccharide (LPS) is...

    Yu** **, Hyesu Jeon, ... Kyung-Sun Heo in Archives of Pharmacal Research
    Article 09 November 2023
  16. Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions

    The emergence of antibody-drug conjugates (ADCs) as a potential therapeutic avenue in cancer treatment has garnered significant attention. By...

    Shivangi Kumari, Sonam Raj, ... Jasvinder Singh Bhatti in Archives of Pharmacal Research
    Article 28 December 2023
  17. Synthesis, Antiproliferative Activity, and Effect on Carcinoma A549 Cell Microtubules of New Tubuloclustin Analogs

    Combretastatin analogs of the antitumor agent tubuloclustin { N -[7-(adamant-2-yloxy)-7-oxoheptanoyl]- N deacetylcolchicine} were prepared via...

    N. A. Zefirov, Yu. A. Evteeva, ... O. N. Zefirova in Pharmaceutical Chemistry Journal
    Article 01 August 2019
  18. In vivo evaluation of a microtubule PET ligand, [11C]MPC-6827, in mice following chronic alcohol consumption

    Background

    Excessive alcohol consumption is a global health burden and requires a better understanding of its neurobiology. A lower density of brain...

    J. S. Dileep Kumar, Andrei Molotkov, ... Akiva Mintz in Pharmacological Reports
    Article 07 September 2021
  19. Antibody drug conjugates as targeted cancer therapy: past development, present challenges and future opportunities

    Antibody drug conjugates (ADCs) are promising cancer therapeutics with minimal toxicity as compared to small cytotoxic molecules alone and have shown...

    Ritwik Maiti, Bhumika Patel, ... Nirav Dhanesha in Archives of Pharmacal Research
    Article 18 April 2023
  20. Synthesis, Antiproliferative, and Molecular Docking Studies of 3-Mercapto-1,2,4-Triazole Derivatives as Combretastatin A-4 Analogs

    In the present work, a series of 1,2,4-triazole derivatives are designed as combretastatin A-4 analogs with the 4-nitrophenyl group and different...

    Asim A. Balakit, Rajab Abu-El-Halawa, ... Elaf S. Alsultan in Pharmaceutical Chemistry Journal
    Article 01 October 2023
Did you find what you were looking for? Share feedback.